DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 06 · Volume 31 · November 1998 DOI: 10.1055/s-002-6333

Original Papers

  • 205
    Scherbaum, N.; Klein, S.; Kaube, H.; Kienbaum, P.; Peters, J.; Gastpar, M.:

    Alternative Strategies of Opiate Detoxification: Evaluation of the So-called Ultra-Rapid Detoxification

  • 216
    Marchesi, C.; Ceccherininelli, A.; Rossi, A.; Maggini, C.:

    Is Anxious-Agitated Major Depression Responsive to Fluoxetine? A Double-Blind Comparison with Amitriptyline

  • 222
    Munzel, U.; Bandelow, B.:

    The Use of Parametric vs. Nonparametric Tests in the Statistical Evaluation of Rating Scales

  • 225
    Winterer, G.; Ziller, M.; Linden, M.:

    Classification of Observational Data with Artificial Neural Networks Versus Discriminant Analysis in Pharmacoepidemiological Studies - Can Outcome of Fluoxetine Treatment be Predicted?

  • 232
    Soyka, M.; Aichmüller, C.; Preuss, U.; Möller, H.-J.:

    Effects of Acamprosate on Psychomotor Performance and Driving Ability in Abstinent Alcoholics

    • Review

  • 210
    Schou, M.:

    Has the Time Come to Abandon Prophylactic Lithium Treatment? A Review for Clinicians

    • Case Report

  • 236
    Verbeeck, W. J. C.; Berk, M.:

    Clozapine Associated Neutropenia and Cytomegalovirus Colitis

  • 238
    Szelényi, A.; Albrecht, J.:

    Tranylcypromine Abuse Associated with an Isolated Thrombocytopenia

  • 241
    Benazzi, F.:

    Risperidone-induced Hepatotoxicity